For the Right Perspective & Competitive Insights. Make confident decisions using our benchmarks and analysis.
Download FREE Sample Report
Read the 120-page report with TOC on "Human Vaccine Market Analysis Report by Geography (North America, Europe, Asia, and ROW) and RoA (Intramuscular, Subcutaneous, Oral, and Others), and the Segment Forecasts, 2021-2025". Gain competitive intelligence about market leaders. Track key industry opportunities, trends, and threats. Information on marketing, brand, strategy and market development, sales and supply functions.
More Details: https://www.technavio.com/report/report/human-vaccine-market-industry-analysis
The human vaccine market is driven by the increase in investments in the vaccines segment. In addition, the need for novel vaccines for chronic infections is anticipated to boost the growth of the human vaccine market.
High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management. Companies across the world are increasingly investing in new vaccine development. The significant increase in capacity is to meet the growing demand for pediatric and booster vaccines. In February 2018, Prokarium, a UK-based synthetic biology company, announced the completion of a $10 million investment round. The investment was focused on the clinical development of vaccines against chlamydia, C. difficile, and enteric fever (typhoid and paratyphoid). The fund included R&D in immuno-oncology team expansion. Globally, the increasing investments in the vaccine market indicate a promising future demand.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Major Five Human Vaccine Companies:
Bavarian Nordic AS
Bavarian Nordic AS operates business through the Unified business segment. The company offers human vaccines such as the Ebola vaccine and Rabipur/RabAvert.
CSL Ltd.
CSL Ltd. operates business through CSL Behring and Seqirus. The company offers human vaccines such as Afuria, Agrippal, Flaud, and Flucelvax Quadrivalent.
Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. operates business through Innovative Pharmaceuticals, Generic, Vaccine, and OTC Related. The company offers a variety of human vaccines.
GlaxoSmithKline Plc
GlaxoSmithKline Plc operates business through Pharmaceuticals, Consumer Healthcare, and Vaccines. The company offers human vaccines such as Ambirix, BEXSERO, BOOSTRIX, and CERVARIX.
Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc. operates business through the Immunotherapies segment. VGX-3100 is a therapeutic DNA vaccine being investigated in Phase III clinical trial for the treatment of pre-cancers and cancers, such as cervical cancer, caused by the HPV subtypes 16 and 18.
Human Vaccine Market Geography Outlook (Revenue, USD billion, 2020-2025)
- North America - size and forecast 2020-2025
- Europe - size and forecast 2020-2025
- Asia - size and forecast 2020-2025
- ROW - size and forecast 2020-2025
Human Vaccine Market RoA Outlook (Revenue, USD billion, 2020-2025)
- Intramuscular - size and forecast 2020-2025
- Subcutaneous - size and forecast 2020-2025
- Oral - size and forecast 2020-2025
- Others - size and forecast 2020-2025
Are you a start-up willing to make it big in the business? Grab an exclusive Report
Related Reports on Health Care Include:
Global Monoclonal Antibodies Market- The monoclonal antibodies market is segmented by application (oncology, autoimmune disorders, infectious diseases, and other applications), geography (North America, Europe, Asia, and ROW), and key vendors.
Download FREE Sample Report
Global Alcoholic Hepatitis Treatment Market- The alcoholic hepatitis treatment market is segmented by type (corticosteroids, xanthine derivatives, and others), geography (North America, Europe, Asia, and ROW), and key vendors.
Download FREE Sample Report
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report Page: https://www.technavio.com/report/human-vaccine-market-industry-analysis
SOURCE Technavio
Share this article